224 related articles for article (PubMed ID: 26886341)
1. Alteration in Intrapulmonary Pharmacokinetics of Aerosolized Model Compounds Due to Disruption of the Alveolar Epithelial Barriers Following Bleomycin-Induced Pulmonary Fibrosis in Rats.
Togami K; Chono S; Tada H
J Pharm Sci; 2016 Mar; 105(3):1327-34. PubMed ID: 26886341
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-β
Togami K; Yamaguchi K; Chono S; Tada H
J Pharmacol Toxicol Methods; 2017 Jul; 86():19-27. PubMed ID: 28259823
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized Liposomal Formulation Prevents Enhanced Drug Transfer from Fibrotic Lungs to the Systemic Circulation.
Togami K; Kurasho K; Kanehira Y; Tada H; Chono S
Curr Drug Deliv; 2021; 18(7):947-954. PubMed ID: 33372874
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis.
Ohta H; Chiba S; Ebina M; Furuse M; Nukiwa T
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(2):L193-205. PubMed ID: 22003091
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
7. Heterogenous Intrapulmonary Distribution of Aerosolized Model Compounds in Mice with Bleomycin-Induced Pulmonary Fibrosis.
Togami K; Kanehira Y; Yumita Y; Ozaki H; Wang R; Tada H; Chono S
J Aerosol Med Pulm Drug Deliv; 2023 Dec; 36(6):289-299. PubMed ID: 37843890
[No Abstract] [Full Text] [Related]
8. [Intrapulmonary Pharmacokinetics and Drug Distribution Characteristics for the Treatment of Respiratory Diseases].
Togami K
Yakugaku Zasshi; 2020; 140(3):345-354. PubMed ID: 32115551
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice.
Gupte VV; Ramasamy SK; Reddy R; Lee J; Weinreb PH; Violette SM; Guenther A; Warburton D; Driscoll B; Minoo P; Bellusci S
Am J Respir Crit Care Med; 2009 Sep; 180(5):424-36. PubMed ID: 19498056
[TBL] [Abstract][Full Text] [Related]
10. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
[TBL] [Abstract][Full Text] [Related]
11. Prolonged distribution of aerosolized PEGylated liposomes in the lungs of mice with bleomycin-induced pulmonary fibrosis.
Togami K; Maruta Y; Nanbu M; Tada H; Chono S
Drug Dev Ind Pharm; 2020 Nov; 46(11):1873-1880. PubMed ID: 32940095
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis.
Gazdhar A; Fachinger P; van Leer C; Pierog J; Gugger M; Friis R; Schmid RA; Geiser T
Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L529-36. PubMed ID: 17056705
[TBL] [Abstract][Full Text] [Related]
13. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
14. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis.
Tian R; Zhu Y; Yao J; Meng X; Wang J; Xie H; Wang R
Exp Cell Res; 2017 Aug; 357(2):328-334. PubMed ID: 28591554
[TBL] [Abstract][Full Text] [Related]
16. Epithelial Pten controls acute lung injury and fibrosis by regulating alveolar epithelial cell integrity.
Miyoshi K; Yanagi S; Kawahara K; Nishio M; Tsubouchi H; Imazu Y; Koshida R; Matsumoto N; Taguchi A; Yamashita S; Suzuki A; Nakazato M
Am J Respir Crit Care Med; 2013 Feb; 187(3):262-75. PubMed ID: 23239155
[TBL] [Abstract][Full Text] [Related]
17. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
18. Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis.
Andreutti D; Gabbiani G; Neuville P
Lab Invest; 1998 Dec; 78(12):1493-502. PubMed ID: 9881949
[TBL] [Abstract][Full Text] [Related]
19. Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib-hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis.
Togami K; Ogasawara A; Irie S; Iwata K; Yamaguchi K; Tada H; Chono S
Eur J Pharm Biopharm; 2022 Mar; 172():203-212. PubMed ID: 35183716
[TBL] [Abstract][Full Text] [Related]
20. TGF-β1-induced deposition of provisional extracellular matrix by tracheal basal cells promotes epithelial-to-mesenchymal transition in a c-Jun NH
van der Velden JL; Wagner DE; Lahue KG; Abdalla ST; Lam YW; Weiss DJ; Janssen-Heininger YMW
Am J Physiol Lung Cell Mol Physiol; 2018 Jun; 314(6):L984-L997. PubMed ID: 29469614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
